Rezpegaldesleukin Long-Term Data Unveiled at EADV 2026
New rezpegaldesleukin data presented at EADV Congress 2026 support long-term durability and disease improvement in both alopecia areata and atopic dermatitis patients.
Topic
Topic
New rezpegaldesleukin data presented at EADV Congress 2026 support long-term durability and disease improvement in both alopecia areata and atopic dermatitis patients.